Rock Springs Capital Management’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.46M | Buy |
83,982
+900
| +1% | +$26.4K | 0.15% | 75 |
|
2025
Q1 | $2.14M | Buy |
83,082
+53,777
| +184% | +$1.38M | 0.12% | 78 |
|
2024
Q4 | $846K | Buy |
+29,305
| New | +$846K | 0.03% | 100 |
|
2022
Q2 | – | Sell |
-255,822
| Closed | -$9.13M | – | 139 |
|
2022
Q1 | $9.13M | Sell |
255,822
-41,165
| -14% | -$1.47M | 0.23% | 84 |
|
2021
Q4 | $25.8M | Buy |
296,987
+314
| +0.1% | +$27.3K | 0.6% | 53 |
|
2021
Q3 | $34M | Sell |
296,673
-10,718
| -3% | -$1.23M | 0.72% | 47 |
|
2021
Q2 | $66.1M | Buy |
+307,391
| New | +$66.1M | 1.31% | 21 |
|